May 31, 2023

Featuring perspectives from Prof Sia Daneshmand, Dr Joshua J Meeks, Dr Matthew Milowsky and Prof J Alfred Witjes, moderated by Dr Arlene Siefker‑Radtke, including the following topics:

• Introduction (0:00)
• Current Role of Anti-PD-1/PD-L1 Antibodies in the Treatment of Non-Muscle-Invasive Bladder Cancer — Joshua...

May 30, 2023

Featuring perspectives from Dr Ahmed Omar Kaseb, Ms Blanca Ledezma, Dr Daneng Li and Ms Amanda K Wagner, including the following topics:

• Introduction (0:00)
• Overview of Hepatocellular Carcinoma (HCC) (3:37)
• First-Line Systemic Therapy for HCC (27:37)
• Therapy for Relapased HCC (41:43)
• Overview of Biliary Tract Cancers...

May 25, 2023

Featuring perspectives from Dr John N Allan, Ms Jacqueline Broadway‑Duren, Ms Corinne Hoffman and Dr Adam S Kittai, including the following topics:

• Introduction (0:00)
• Overview of Chronic Lymphocytic Leukemia (CLL) (5:20)
• First-Line Therapy for CLL (32:06)
• Use of Venetoclax in Combination with an Anti-CD20 Antibody...

May 24, 2023

Featuring perspectives from Dr Himisha Beltran, Dr Stephen J Freedland, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Matthew R Smith, including the following topics:

• Introduction (0:00)
• Management Approaches for Nonmetastatic Prostate Cancer — Dr Freedland (1:45)
• Optimizing the Care of Patients with Metastatic...

May 22, 2023

Featuring perspectives from Dr Stephen V Liu, Ms Tara Plues, Ms Jillian Thompson and Dr Anne S Tsao, including the following topics:

• Introduction (0:00)
• Immunotherapy for Nonmetastatic and Metastatic Non-Small Cell Lung Cancer (NSCLC) (5:47)
• Future Directions — Tumor Treating Fields (37:30)
• Overview of...